Connecticut Certification Board
Connecticut Certification Board
Unintended Consequences: The DEA and Medications for Substance Use Treatment
Unintended Consequences: The DEA and Medications for Substance Use Treatment
Unintended Consequences: The DEA and Medications for Substance Use Treatment
Wednesday 1st December 2021
Guest host Kapil Nayar and the Connecticut Certification Board discuss how DEA policies affect medication-assisted addiction treatment and pharmacies.
31 minutes
Informative
Thought-provoking
Engaging
Raw
Supportive
About this podcast
Author:
Connecticut Certification Board
Overview:
Categories:
Sobriety Toolkit
Innovative Treatments & Recovery Paths
Family Recovery from Addiction
Recovery from Trauma
Navigating Intimate Relationships
Links:
Visit site
Episodes:
91 (View all)
Do you want to link to this podcast?
Get the buttons here!DEA Policies and Their Ripple Effect on Addiction Treatment
The actions here kind of play into the anti-medication bias that does exist in the field, and I don't think that the Dea meant to do that.
What happens when the very policies meant to control substance abuse end up hindering recovery? This episode of 'Scope of Practice' tackles this pressing issue head-on. Guest host Kapil Nayar joins the Connecticut Certification Board to dissect a recent Kaiser Health News article that reveals how DEA blanket enforcement efforts are inadvertently harming those who rely on medication for their recovery, as well as the pharmacies that serve them.
The conversation kicks off with the poignant story of Martin Njoku, a pharmacist in West Virginia whose business took a severe hit due to these enforcement measures. From there, the discussion broadens to explore the impact on crucial medications like Buprenorphine and Suboxone, which are essential for harm reduction and successful treatment. The hosts also dive into the existing anti-medication bias within the addiction treatment field and highlight the lack of comprehensive outcome studies to ensure quality care.
They don't shy away from addressing the unique challenges faced by rural communities in accessing treatment. As the episode unfolds, it becomes clear that a broader perspective is needed to fully understand the unintended consequences of DEA policies. By the end, listeners are left with a call to action: to consider the larger system and its myriad moving parts. This episode is a must-listen for anyone interested in the complexities of addiction treatment and the real-world impact of regulatory policies.